Published in J Clin Oncol on December 10, 2007
Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer (2012) 0.89
Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol (2013) 0.87
Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy. Biomed Res Int (2013) 0.79
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med (2012) 4.10
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis (2013) 3.10
Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Med Phys (2008) 2.84
Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) (2011) 2.62
Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res (2003) 2.61
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell (2010) 1.88
Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci (2010) 1.87
Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol (2009) 1.80
Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol (2008) 1.70
Development of an MR-compatible SPECT system (MRSPECT) for simultaneous data acquisition. Phys Med Biol (2010) 1.69
Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol (2007) 1.51
Design and implementation of a multifrequency near-infrared diffuse optical tomography system. J Biomed Opt (2006) 1.46
In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. Appl Opt (2003) 1.46
Whole breast lesion detection using naive bayes classifier for portable ultrasound. Ultrasound Med Biol (2012) 1.44
Quantitative fluorescence tomography with functional and structural a priori information. Appl Opt (2009) 1.44
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer (2008) 1.44
Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging (2003) 1.40
Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA (2006) 1.40
Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy. Philos Trans A Math Phys Eng Sci (2011) 1.38
Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat (2006) 1.37
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. J Alzheimers Dis (2014) 1.36
Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat (2003) 1.34
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology (2009) 1.34
Cognitive dysfunction after experimental febrile seizures. Exp Neurol (2008) 1.28
Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system. Opt Express (2010) 1.28
Dependent pooling: a contrast-enhanced sign of cardiac arrest during CT. AJR Am J Roentgenol (2002) 1.27
Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox. J Clin Oncol (2008) 1.27
Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death. Ann Neurol (2004) 1.26
Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma (2007) 1.24
Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol (2009) 1.24
A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. Med Phys (2011) 1.23
TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res (2008) 1.23
Development of a new RF coil and gamma-ray radiation shielding assembly for improved MR image quality in SPECT/MRI. Phys Med Biol (2010) 1.22
Diagnosis of hepatic tumors with texture analysis in nonenhanced computed tomography images. Acad Radiol (2006) 1.15
Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol (2002) 1.15
MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging (2007) 1.13
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res (2009) 1.12
Multicentric aggressive angiomyolipomas: a rare form of PEComas. AJR Am J Roentgenol (2006) 1.12
Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res (2013) 1.09
Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol (2010) 1.09
Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys (2010) 1.05
VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab Invest (2003) 1.05
Impact of skin removal on quantitative measurement of breast density using MRI. Med Phys (2010) 1.04
The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun (2006) 1.04
Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 1.04
In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol (2007) 1.03
Diffuse optical tomographic reconstruction using multifrequency data. J Biomed Opt (2006) 1.03
Mild cognitive impairment: apparent diffusion coefficient in regional gray matter and white matter structures. Radiology (2006) 1.03
Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer (2009) 1.02
Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci (2004) 1.01
Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging (2007) 1.01
An integrative modeling approach to elucidate suction-feeding performance. J Exp Biol (2012) 1.00
Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging (2008) 1.00
Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys (2011) 0.99
The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun (2006) 0.99
Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology (2010) 0.98
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology (2011) 0.97
Integrating the determinants of suction feeding performance in centrarchid fishes. J Exp Biol (2008) 0.97